Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes

Completed · Phase 2

Conditions studied: Prostate Cancer

In brief

The purpose of this study is to examine the clinical feasibility and efficacy of uing IMRT to escalate the biologically effective dose to the pelvic lymph nodes in a short course of radiation therapy. An increased total and biologically effective dose will be delivered to the pelvic lymph nodes (56 Gy at 2 Gy/fraction). The prostate will receive standard "short course" IMRT of radiation (70 Gy at 2.5 Gy/fraction).

Key facts

Study ID

NCT00214136

Run by

University of Wisconsin, Madison

People needed

30

Starts

2005-03-01

Expected to finish

2016-03-01

Last updated by the study team

2021-08-04

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Prostate cancer stage T-T3
• Predicted risk of lymph node involvement > 15%
• Gleason > 7

You may not qualify if…

• Distance metastases
• Use of anti-coagulant therapy

Where it is running

• University Of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.